Endpoint definition
↥Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
No definition available.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Drugs, medicaments and biological substances causing adverse effects in therapeutic use based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 24 | 13 | 11 |
Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
Mean age at first event (years) | 64.29 | 66.20 | 62.03 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | - | - | - | - |
15 years | - | - | - | - |
5 years | - | - | - | - |
1 year | - | - | - | - |
Index endpoint: VWXY20_DRUGS_MEDICAM_BIOLO_SUBST_CAUSI_ADVER_EFFEC_THERAPE_USE – Drugs, medicaments and biological substances causing adverse effects in therapeutic use
GWS hits:
before Drugs, medicaments and biological substances causing adverse effects in therapeutic use
after Drugs, medicaments and biological substances causing adverse effects in therapeutic use
Loading survival analyses plot
Loading survival analyses table